These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 17695283

  • 1. [Prevention of prion disease transmission].
    Kishida H, Kuroiwa Y.
    Nihon Rinsho; 2007 Aug; 65(8):1454-9. PubMed ID: 17695283
    [Abstract] [Full Text] [Related]

  • 2. [Acquired Creutzfeldt-Jakob disease (CJD)--Kuru, iatrogenic CJD, variant CJD].
    Sanjo N.
    Nihon Rinsho; 2007 Aug; 65(8):1438-45. PubMed ID: 17695281
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Infectious prion disease: CJD with dura mater transplantation].
    Sato T.
    Rinsho Shinkeigaku; 2003 Nov; 43(11):870-2. PubMed ID: 15152489
    [Abstract] [Full Text] [Related]

  • 5. Human prion diseases: surgical lessons learned from iatrogenic prion transmission.
    Bonda DJ, Manjila S, Mehndiratta P, Khan F, Miller BR, Onwuzulike K, Puoti G, Cohen ML, Schonberger LB, Cali I.
    Neurosurg Focus; 2016 Jul; 41(1):E10. PubMed ID: 27364252
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Managing the risk of transmission of variant Creutzfeldt Jakob disease by blood products.
    Ludlam CA, Turner ML.
    Br J Haematol; 2006 Jan; 132(1):13-24. PubMed ID: 16371015
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Tissue safety in view of CJD and variant CJD.
    Pauli G.
    Cell Tissue Bank; 2005 Jan; 6(3):191-200. PubMed ID: 16151959
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Iatrogenic Creutzfeldt-Jakob disease: the waning of an era.
    Brown P, Brandel JP, Preece M, Sato T.
    Neurology; 2006 Aug 08; 67(3):389-93. PubMed ID: 16855204
    [Abstract] [Full Text] [Related]

  • 12. Clinicopathologic characteristics of five autopsied cases of dura mater-associated Creutzfeldt-Jakob disease.
    Iwasaki Y, Mimuro M, Yoshida M, Hashizume Y, Kitamoto T, Sobue G.
    Neuropathology; 2008 Feb 08; 28(1):51-61. PubMed ID: 18181835
    [Abstract] [Full Text] [Related]

  • 13. Risk of prion disease transmission from ocular donor tissue transplantation.
    Hogan RN, Brown P, Heck E, Cavanagh HD.
    Cornea; 1999 Jan 08; 18(1):2-11. PubMed ID: 9894930
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Managing the risk of iatrogenic transmission of Creutzfeldt-Jakob disease in the UK.
    Hall V, Brookes D, Nacul L, Gill ON, Connor N, CJD Incidents Panel.
    J Hosp Infect; 2014 Sep 08; 88(1):22-7. PubMed ID: 25082752
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Transmissible spongiform encephalopathies--anesthesiologic and intensive care management].
    Menges T, Langefeld TW, Krumholz W, Hempelmann G.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2001 Feb 08; 36(2):79-89. PubMed ID: 11269018
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Methods to minimize the risks of Creutzfeldt-Jakob disease transmission by surgical procedures: where to set the standard?
    Sutton JM, Dickinson J, Walker JT, Raven ND.
    Clin Infect Dis; 2006 Sep 15; 43(6):757-64. PubMed ID: 16912952
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.